Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/19/26 18:41 | 3/17/26 | CTMX | Health | Drug | Pharmaceutical Preparations | Chu Yu-Waye | CA | O | Chief Me | 1 | S | -137 | 6.42 | 0 | -21 | 189 | D | |||||||||||||||
3/19/26 18:35 | 3/17/26 | CTMX | Health | Drug | Pharmaceutical Preparations | McCarthy Sean A. | CA | DO | CEO | 1 | S | -764 | 6.42 | 0 | -119 | 1,172 | D | |||||||||||||||
3/19/26 18:25 | 3/17/26 | CTMX | Health | Drug | Pharmaceutical Preparations | Belvin Marcia | CA | O | SVP,Chie | 1 | S | -202 | 6.42 | 0 | -31 | 301 | D | |||||||||||||||
3/19/26 18:21 | 3/17/26 | CTMX | Health | Drug | Pharmaceutical Preparations | Ogden Christopher | CA | O | CFO | 1 | S | -124 | 6.42 | 0 | -19 | 297 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |